Skip to main content
¿Habla español?
Comuníquese con nuestra mesa de ayuda 24/7/365 al 877-635-9545.
Young businesswoman using a digital tablet while standing in front of windows in office Young businesswoman using a digital tablet while standing in front of windows in office Young businesswoman using a digital tablet while standing in front of windows in office

ProAct
Resources

 

Inflation Reduction Act (IRA) Impact on Medicare Part D in 2025

Inflation Reduction Act (IRA) Impact on Medicare Part D in 2025 hero image

The 2022 Inflation Reduction Act (IRA) makes significant changes to the Medicare Part D standard benefit, including capping annual enrollee out-of-pocket spending. The new provisions are being implemented gradually through 2025. While some changes…

Actions to Resolve Drug Shortages

Actions to Resolve Drug Shortages hero image

In the first quarter of 2024, The American Society of Health-System Pharmacists (ASHP) reported an estimated 323 active drug shortages, slightly exceeding the previous record of 320 shortages set in 2014. In light of…

GLP-1 Shortage and Compounding

GLP-1 Shortage and Compounding hero image

The rapidly growing popularity of glucagon-like peptide 1 (GLP-1) receptor agonists for use in weight loss has led to widespread shortages of…

Drug Trend Mid-Year Update

Drug Trend Mid-Year Update hero image

Through June 30, 2024, the FDA approved 27 novel pharmaceutical products for use in the United States. While 2023 was a record-breaking year with 72 novel approvals, this year is expected to approach that number. Of the novel approval’s…

Authorized Generic for Victoza® Launched

Authorized Generic for Victoza® Launched hero image

On June 24, 2024, Teva announced the launch of an authorized generic for Victoza® (liraglutide injection 1.8mg).…

ProAct Logo ProAct Logo ProAct Logo
mobile image tablet image desktop image